Related Experiment Videos
VIP gene transcription is regulated by far upstream enhancer and repressor elements
1Department of Psychiatry and Mental Retardation Research Center, University of California at Los Angeles, 760 Westwood Plaza, Room 68-225 NPI, Los Angeles, California, 90024-1759
Biochemical and Biophysical Research Communications
|May 26, 2001
Summary
Researchers identified key regulatory elements in the vasoactive intestinal peptide (VIP) gene. These findings reveal how VIP gene transcription is finely tuned in neuroblastoma cells.
Area of Science:
- Neuroscience
- Molecular Biology
- Genetics
Background:
- Human neuroblastoma cell lines exhibit significant variations in vasoactive intestinal peptide (VIP) gene expression.
- These differences are linked to both basal activity and responses to second messenger induction.
Purpose of the Study:
- To investigate the regulatory mechanisms controlling the human VIP gene.
- To identify and characterize specific DNA sequences responsible for regulating VIP gene transcription.
Main Methods:
- Utilized a chimeric gene construct combining the human VIP 5' flanking sequence with a reporter gene.
- Performed sequential gene deletion and mutation analyses on the VIP upstream regulatory region.
- Investigated the function of specific DNA fragments through transcription assays.
Main Results:
- Identified a 645-bp upstream regulatory region critical for VIP gene expression.
- Deletion of inhibitory sequences from the 645-bp fragment resulted in over a 50-fold increase in basal transcription.
- Characterized a 213-bp fragment containing at least two enhancer elements, including an AT-rich sequence binding Oct proteins and a composite AP-1/ets element.
- Discovered a novel 28-bp silencer element within the 213-bp fragment.
Conclusions:
- The VIP gene possesses a complex regulatory region upstream of the transcription start site.
- This region contains both enhancer and silencer elements that precisely modulate VIP gene transcription.
- These findings provide molecular insights into the fine-tuning of VIP gene expression in vivo, particularly in neuroblastoma contexts.